Gilead Sciences, Inc. (GILD)
123.41
+2.07
(+1.71%)
USD |
NASDAQ |
Dec 11, 15:19
Gilead Sciences Free Cash Flow: 9.162B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Johnson & Johnson | 20.46B |
| Eli Lilly & Co. | 6.436B |
| Merck & Co., Inc. | 13.05B |
| Pfizer Inc. | 10.38B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.108B |
| Cash from Investing (Quarterly) | -427.00M |
| Cash from Financing (Quarterly) | -1.489B |
| Free Cash Flow Per Share (Quarterly) | 3.159 |
| Free Cash Flow to Equity (Quarterly) | 3.966B |
| Free Cash Flow to Firm (Quarterly) | 4.176B |
| Free Cash Flow Yield | 5.91% |